Open AccessA Phase I Study of Visilizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Severe Steroid-Refractory Ulcerative Colitis
Author(s) -
Scott E. Plevy,
Bruce Salzberg,
Gert Van Assche,
Miguel Regueiro,
Daniël W. Hommes,
William J. Sandborn,
Stephen B. Hanauer,
Stephan R. Targan,
Lloyd Mayer,
Uma M,
Matthew Frankel,
James N. Lowder
Publication year - 2007
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/g98r-2070
Subject(s) - ulcerative colitis , refractory (planetary science) , medicine , monoclonal antibody , monoclonal , antibody , colitis , immunology , biology , disease , astrobiology